Related Experiment Videos
Experience with antisyphon devices: successes and complications
1Sub-Dept. of Paediatric Surgery, Children's Hospital, Western Bank, Sheffield, U.K.
Summary
Antisyphon devices effectively treated slit ventricle syndrome in 16 of 20 children. While ventricular dilatation was maintained in 70% of primary implantations, re-expansion was uncommon. Complications were also reviewed.
Area of Science:
- Pediatric Neurosurgery
- Medical Device Technology
Background:
- Slit ventricle syndrome is a challenging complication of cerebrospinal fluid shunt surgery.
- Maintaining appropriate ventricular size is crucial for managing hydrocephalus.
Purpose of the Study:
- To evaluate the efficacy and outcomes of antisyphon devices in pediatric patients.
- To assess the impact of antisyphon devices on ventricular size and symptom resolution.
Main Methods:
- Retrospective analysis of 30 pediatric patients receiving antisyphon devices.
- Two groups: primary implantation (10 children) and treatment for slit ventricle syndrome (20 children).
- Assessment of ventricular size maintenance and symptom relief.
Main Results:
- Antisyphon devices maintained ventricular dilatation in 70% (7/10) of primary implantations with follow-up.
- 16 of 20 children (80%) with slit ventricle syndrome became symptom-free.
- Ventricular re-expansion was infrequent in the slit ventricle syndrome group.
Conclusions:
- Antisyphon devices demonstrate significant efficacy in managing slit ventricle syndrome and maintaining ventricular size.
- Further investigation into optimizing ventricular re-expansion and managing complications is warranted.